| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 12.610 | 26.866 | 12.892 | 869 | 4.624 |
| Total Income - EUR | - | - | - | - | - | 12.610 | 26.866 | 12.892 | 870 | 4.624 |
| Total Expenses - EUR | - | - | - | - | - | 12.403 | 18.196 | 12.533 | 15.154 | 1.786 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 208 | 8.669 | 358 | -14.285 | 2.838 |
| Net Profit/Loss - EUR | - | - | - | - | - | 86 | 8.433 | 249 | -14.293 | 2.384 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Diadiab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 530 | 37 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 2.400 | 16.822 | 9.142 | 3 | 87 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.116 | 16.817 | 8.760 | 0 | 5 |
| Cash | - | - | - | - | - | 1.283 | 5 | 382 | 3 | 81 |
| Shareholders Funds | - | - | - | - | - | 69 | 8.500 | 8.775 | -5.545 | -3.130 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.861 | 8.358 | 367 | 5.547 | 3.217 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diadiab S.r.l.